Phase II Trial Of Induction Chemotherapy Followed By Attenuated Chemoradiotherapy For Locally Advanced Head And Neck Squamous Cell Carcinoma Associated With Human Papillomavirus (HPV)
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Carboplatin; Paclitaxel
- Indications Head and neck cancer
- Focus Therapeutic Use
- 26 Feb 2021 Biomarkers information updated
- 10 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Dec 2012 New trial record